Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Browse Research Guides Explore Research Library KLOW Blend Research FAQs What is KLOW Blend
All experiments should follow institutional safety protocols, including protective equipment and responsible disposal
Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction
15 BladtF.RiethmacherD.IsenmannS.AguzziA.BirchmeierC
- Exhibits anti-inflammatory properties
The intervention group consisted of patients who were prescribed GLP-1 RA medications, including Victoza (Liraglutide 1.8 mg), Saxenda (Liraglutide 3 mg), Ozempic (Semaglutide 1 mg), and Wegovy (Semaglutide 2.4 mg)
US$ 26.09
US$ 26.40
US$ 27.89
US$ 20.31
US$ 26.88
US$ 20.57
US$ 25.27
US$ 21.74
